Our Therapy Areas
Endocrinology & Metabolic trials
Our Endocrinology and metabolic trials focus on studying conditions related to the endocrine system (glands that release hormones) and metabolic disorders. Our investigators have a wealth of experience in Endocrinology & Metabolic trials for conditions such as diabetes, thyroid disorders, obesity, and adrenal insufficiency, among others.
Obesity
Our Obesity trials are designed to evaluate interventions, treatments, and strategies aimed at preventing, managing, or reducing obesity. Our PIs have experience in the specific challenges of these trials to ensure high patient retention and quality data.
9 experienced FutureMeds Investigators
Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by high blood glucose levels resulting from a combination of insulin resistance and impaired insulin secretion. Our site teams have the experts, experience and equipment to deliver high quality Type 2 Diabetes Trials.
43 experienced FutureMeds Investigators
CKD
Chronic Kidney Disease (CKD) is a long-term condition characterized by a gradual decline in kidney function over time. CKD impairs filtering waste products from the blood, maintaining electrolyte balance, and regulating blood pressure, which can lead to various health complications. Our experts have experience in conducting CKD trials across Europe.
5 experienced FutureMeds Investigators
NASH
Nonalcoholic Steatosis Hepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD) characterized by inflammation and damage to the liver due to fat accumulation, in the absence of significant alcohol consumption. Our experienced teams have conducted multiple trials across Europe to give patients access to the latest innovative treatments.
14 experienced FutureMeds Investigators
“Endocrinology and Metabolic research lies at the heart of understanding the intricate balance that sustains human health. We are deeply committed to this field, driven by a passion for making progress that directly improves patient lives. Every trial has the potential to bring us closer to transforming patient experiences, offering hope and solutions where they are needed most.”
